FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 34 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $766,391 | +48375.1% | 86,794 | -54.3% | 0.00% | -100.0% |
| Q1 2023 | $1,581 | +29.4% | 189,998 | +49.3% | 0.00% | 0.0% |
| Q4 2022 | $1,222 | -99.9% | 127,289 | -48.9% | 0.00% | 0.0% |
| Q3 2022 | $2,020,000 | +50.6% | 249,337 | +5.0% | 0.00% | 0.0% |
| Q2 2022 | $1,341,000 | -5.2% | 237,392 | -6.0% | 0.00% | 0.0% |
| Q1 2022 | $1,415,000 | +24.8% | 252,679 | -1.9% | 0.00% | 0.0% |
| Q4 2021 | $1,134,000 | -53.3% | 257,617 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,427,000 | -17.8% | 257,621 | -36.4% | 0.00% | -50.0% |
| Q2 2021 | $2,951,000 | +2488.6% | 404,772 | +2010.4% | 0.00% | – |
| Q1 2020 | $114,000 | -40.3% | 19,180 | -59.7% | 0.00% | – |
| Q2 2019 | $191,000 | -82.9% | 47,634 | -48.6% | 0.00% | -100.0% |
| Q1 2018 | $1,120,000 | – | 92,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |